Literature DB >> 29297141

Lactulose: A Simple Sugar in a Complex Encephalopathy.

Eelco F M Wijdicks1.   

Abstract

Hepatic encephalopathy is a common encephalopathy and one of the very few that are treatable. Lactulose has remained a standard pharmaceutical intervention and is listed as one of the World Health Organization's Essential Medicines. The discovery of lactulose, the acid dialysis proof of concept, and the role of Bircher are not well known. This historical vignette reviews the gradual understanding of the complex liver-brain connection, the effective treatment of hepatic stupor with lactulose, and the immediate relevance of lactulose to the practice of consultative neurocritical care.

Entities:  

Keywords:  Ammonia; Hepatic encephalopathy; Johannes Bircher; Lactulose; Portal-systemic encephalopathy

Mesh:

Substances:

Year:  2018        PMID: 29297141     DOI: 10.1007/s12028-017-0494-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  16 in total

1.  [STUDIES ON THE MECHANISM OF ACTION OF LACTULOSE (BETA-GALACTOSIDE ACTION OF LACTULOSE (BETA-GALACTOSIDO-FRUCTOSE) IN THE INTESTINE].

Authors:  K HOFFMANN; D A MOSSEL; W KORUS; J H VAN DE KAMER
Journal:  Klin Wochenschr       Date:  1964-02-01

2.  Blood-ammonium levels in liver disease and hepatic coma.

Authors:  E A PHEAR; S SHERLOCK; W H SUMMERSKILL
Journal:  Lancet       Date:  1955-04-23       Impact factor: 79.321

3.  The electroencephalograph in liver disease.

Authors:  B G PARSONS-SMITH; W H SUMMERSKILL; A M DAWSON; S SHERLOCK
Journal:  Lancet       Date:  1957-11-02       Impact factor: 79.321

4.  The neurological disorder associated with liver disease.

Authors:  R D ADAMS; J M FOLEY
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1953

Review 5.  Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Authors:  Bodil Als-Nielsen; Lise L Gluud; Christian Gluud
Journal:  BMJ       Date:  2004-03-30

6.  Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

Authors:  S G Elkington; M H Floch; H O Conn
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

7.  Wrong idea, good results (the lactulose story).

Authors:  U P Haemmerli; J Bircher
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

8.  Treatment of chronic portal-systemic encephalopathy with lactulose.

Authors:  J Bircher; J Müller; P Guggenheim; U P Haemmerli
Journal:  Lancet       Date:  1966-04-23       Impact factor: 79.321

Review 9.  Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia.

Authors:  Robert S Rahimi; Don C Rockey
Journal:  Semin Liver Dis       Date:  2016-02-12       Impact factor: 6.115

10.  Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.

Authors:  J Canalese; A E Gimson; C Davis; P J Mellon; M Davis; R Williams
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.